Mogroside V can effectively regulate the insulin resistance of HepG2 cells and improve the blood glucose levels, insulin sensitivity, glucose and lipid metabolism disorders, and oxidative stress in T2DM rats. Here, INS is linked to Disorder of lipid metabolism.